Influenza NA Inhibitor Market
1 Study Coverage
1.1 Influenza NA Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global Influenza NA Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.3 Market by Application
1.3.1 Global Influenza NA Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza NA Inhibitor Sales Estimates and Forecasts 2017-2028
2.2 Global Influenza NA Inhibitor Revenue Estimates and Forecasts 2017-2028
2.3 Global Influenza NA Inhibitor Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Influenza NA Inhibitor Sales by Region
2.4.1 Global Influenza NA Inhibitor Sales by Region (2017-2022)
2.4.2 Global Sales Influenza NA Inhibitor by Region (2023-2028)
2.5 Global Influenza NA Inhibitor Revenue by Region
2.5.1 Global Influenza NA Inhibitor Revenue by Region (2017-2022)
2.5.2 Global Influenza NA Inhibitor Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Influenza NA Inhibitor Sales by Manufacturers
3.1.1 Global Top Influenza NA Inhibitor Manufacturers by Sales (2017-2022)
3.1.2 Global Influenza NA Inhibitor Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza NA Inhibitor in 2021
3.2 Global Influenza NA Inhibitor Revenue by Manufacturers
3.2.1 Global Influenza NA Inhibitor Revenue by Manufacturers (2017-2022)
3.2.2 Global Influenza NA Inhibitor Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Influenza NA Inhibitor Revenue in 2021
3.3 Global Influenza NA Inhibitor Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza NA Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza NA Inhibitor Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza NA Inhibitor Sales by Type
4.1.1 Global Influenza NA Inhibitor Historical Sales by Type (2017-2022)
4.1.2 Global Influenza NA Inhibitor Forecasted Sales by Type (2023-2028)
4.1.3 Global Influenza NA Inhibitor Sales Market Share by Type (2017-2028)
4.2 Global Influenza NA Inhibitor Revenue by Type
4.2.1 Global Influenza NA Inhibitor Historical Revenue by Type (2017-2022)
4.2.2 Global Influenza NA Inhibitor Forecasted Revenue by Type (2023-2028)
4.2.3 Global Influenza NA Inhibitor Revenue Market Share by Type (2017-2028)
4.3 Global Influenza NA Inhibitor Price by Type
4.3.1 Global Influenza NA Inhibitor Price by Type (2017-2022)
4.3.2 Global Influenza NA Inhibitor Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Influenza NA Inhibitor Sales by Application
5.1.1 Global Influenza NA Inhibitor Historical Sales by Application (2017-2022)
5.1.2 Global Influenza NA Inhibitor Forecasted Sales by Application (2023-2028)
5.1.3 Global Influenza NA Inhibitor Sales Market Share by Application (2017-2028)
5.2 Global Influenza NA Inhibitor Revenue by Application
5.2.1 Global Influenza NA Inhibitor Historical Revenue by Application (2017-2022)
5.2.2 Global Influenza NA Inhibitor Forecasted Revenue by Application (2023-2028)
5.2.3 Global Influenza NA Inhibitor Revenue Market Share by Application (2017-2028)
5.3 Global Influenza NA Inhibitor Price by Application
5.3.1 Global Influenza NA Inhibitor Price by Application (2017-2022)
5.3.2 Global Influenza NA Inhibitor Price Forecast by Application (2023-2028)
6 North America
6.1 North America Influenza NA Inhibitor Market Size by Type
6.1.1 North America Influenza NA Inhibitor Sales by Type (2017-2028)
6.1.2 North America Influenza NA Inhibitor Revenue by Type (2017-2028)
6.2 North America Influenza NA Inhibitor Market Size by Application
6.2.1 North America Influenza NA Inhibitor Sales by Application (2017-2028)
6.2.2 North America Influenza NA Inhibitor Revenue by Application (2017-2028)
6.3 North America Influenza NA Inhibitor Market Size by Country
6.3.1 North America Influenza NA Inhibitor Sales by Country (2017-2028)
6.3.2 North America Influenza NA Inhibitor Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Influenza NA Inhibitor Market Size by Type
7.1.1 Europe Influenza NA Inhibitor Sales by Type (2017-2028)
7.1.2 Europe Influenza NA Inhibitor Revenue by Type (2017-2028)
7.2 Europe Influenza NA Inhibitor Market Size by Application
7.2.1 Europe Influenza NA Inhibitor Sales by Application (2017-2028)
7.2.2 Europe Influenza NA Inhibitor Revenue by Application (2017-2028)
7.3 Europe Influenza NA Inhibitor Market Size by Country
7.3.1 Europe Influenza NA Inhibitor Sales by Country (2017-2028)
7.3.2 Europe Influenza NA Inhibitor Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Influenza NA Inhibitor Market Size by Type
8.1.1 Asia Pacific Influenza NA Inhibitor Sales by Type (2017-2028)
8.1.2 Asia Pacific Influenza NA Inhibitor Revenue by Type (2017-2028)
8.2 Asia Pacific Influenza NA Inhibitor Market Size by Application
8.2.1 Asia Pacific Influenza NA Inhibitor Sales by Application (2017-2028)
8.2.2 Asia Pacific Influenza NA Inhibitor Revenue by Application (2017-2028)
8.3 Asia Pacific Influenza NA Inhibitor Market Size by Region
8.3.1 Asia Pacific Influenza NA Inhibitor Sales by Region (2017-2028)
8.3.2 Asia Pacific Influenza NA Inhibitor Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Influenza NA Inhibitor Market Size by Type
9.1.1 Latin America Influenza NA Inhibitor Sales by Type (2017-2028)
9.1.2 Latin America Influenza NA Inhibitor Revenue by Type (2017-2028)
9.2 Latin America Influenza NA Inhibitor Market Size by Application
9.2.1 Latin America Influenza NA Inhibitor Sales by Application (2017-2028)
9.2.2 Latin America Influenza NA Inhibitor Revenue by Application (2017-2028)
9.3 Latin America Influenza NA Inhibitor Market Size by Country
9.3.1 Latin America Influenza NA Inhibitor Sales by Country (2017-2028)
9.3.2 Latin America Influenza NA Inhibitor Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Influenza NA Inhibitor Market Size by Type
10.1.1 Middle East and Africa Influenza NA Inhibitor Sales by Type (2017-2028)
10.1.2 Middle East and Africa Influenza NA Inhibitor Revenue by Type (2017-2028)
10.2 Middle East and Africa Influenza NA Inhibitor Market Size by Application
10.2.1 Middle East and Africa Influenza NA Inhibitor Sales by Application (2017-2028)
10.2.2 Middle East and Africa Influenza NA Inhibitor Revenue by Application (2017-2028)
10.3 Middle East and Africa Influenza NA Inhibitor Market Size by Country
10.3.1 Middle East and Africa Influenza NA Inhibitor Sales by Country (2017-2028)
10.3.2 Middle East and Africa Influenza NA Inhibitor Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Green Cross
11.1.1 Green Cross Corporation Information
11.1.2 Green Cross Overview
11.1.3 Green Cross Influenza NA Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Green Cross Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Green Cross Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Overview
11.2.3 Roche Influenza NA Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Roche Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Influenza NA Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 Henan DaKen Chemical
11.4.1 Henan DaKen Chemical Corporation Information
11.4.2 Henan DaKen Chemical Overview
11.4.3 Henan DaKen Chemical Influenza NA Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Henan DaKen Chemical Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Henan DaKen Chemical Recent Developments
11.5 ATK Chemical
11.5.1 ATK Chemical Corporation Information
11.5.2 ATK Chemical Overview
11.5.3 ATK Chemical Influenza NA Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 ATK Chemical Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 ATK Chemical Recent Developments
11.6 Chemwill Asia Co.,Ltd.
11.6.1 Chemwill Asia Co.,Ltd. Corporation Information
11.6.2 Chemwill Asia Co.,Ltd. Overview
11.6.3 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Chemwill Asia Co.,Ltd. Recent Developments
11.7 Shionogi Co.
11.7.1 Shionogi Co. Corporation Information
11.7.2 Shionogi Co. Overview
11.7.3 Shionogi Co. Influenza NA Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shionogi Co. Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shionogi Co. Recent Developments
11.8 NeoPharm
11.8.1 NeoPharm Corporation Information
11.8.2 NeoPharm Overview
11.8.3 NeoPharm Influenza NA Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 NeoPharm Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 NeoPharm Recent Developments
11.9 Moksha8 Pharma
11.9.1 Moksha8 Pharma Corporation Information
11.9.2 Moksha8 Pharma Overview
11.9.3 Moksha8 Pharma Influenza NA Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Moksha8 Pharma Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Moksha8 Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Influenza NA Inhibitor Industry Chain Analysis
12.2 Influenza NA Inhibitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza NA Inhibitor Production Mode & Process
12.4 Influenza NA Inhibitor Sales and Marketing
12.4.1 Influenza NA Inhibitor Sales Channels
12.4.2 Influenza NA Inhibitor Distributors
12.5 Influenza NA Inhibitor Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Influenza NA Inhibitor Industry Trends
13.2 Influenza NA Inhibitor Market Drivers
13.3 Influenza NA Inhibitor Market Challenges
13.4 Influenza NA Inhibitor Market Restraints
14 Key Findings in The Global Influenza NA Inhibitor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Influenza NA Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Zanamivir
Table 3. Major Manufacturers of Oseltamivir
Table 4. Major Manufacturers of Peramivir
Table 5. Global Influenza NA Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Influenza NA Inhibitor Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Influenza NA Inhibitor Sales by Region (2017-2022) & (Kilotons)
Table 8. Global Influenza NA Inhibitor Sales Market Share by Region (2017-2022)
Table 9. Global Influenza NA Inhibitor Sales by Region (2023-2028) & (Kilotons)
Table 10. Global Influenza NA Inhibitor Sales Market Share by Region (2023-2028)
Table 11. Global Influenza NA Inhibitor Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Influenza NA Inhibitor Revenue Market Share by Region (2017-2022)
Table 13. Global Influenza NA Inhibitor Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Influenza NA Inhibitor Revenue Market Share by Region (2023-2028)
Table 15. Global Influenza NA Inhibitor Sales by Manufacturers (2017-2022) & (Kilotons)
Table 16. Global Influenza NA Inhibitor Sales Share by Manufacturers (2017-2022)
Table 17. Global Influenza NA Inhibitor Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Influenza NA Inhibitor Revenue Share by Manufacturers (2017-2022)
Table 19. Influenza NA Inhibitor Price by Manufacturers (2017-2022) &(US$/Kg)
Table 20. Global Influenza NA Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Influenza NA Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza NA Inhibitor as of 2021)
Table 22. Influenza NA Inhibitor Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Influenza NA Inhibitor Product Offered
Table 24. Date of Manufacturers Enter into Influenza NA Inhibitor Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Influenza NA Inhibitor Sales by Type (2017-2022) & (Kilotons)
Table 27. Global Influenza NA Inhibitor Sales by Type (2023-2028) & (Kilotons)
Table 28. Global Influenza NA Inhibitor Sales Share by Type (2017-2022)
Table 29. Global Influenza NA Inhibitor Sales Share by Type (2023-2028)
Table 30. Global Influenza NA Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Influenza NA Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Influenza NA Inhibitor Revenue Share by Type (2017-2022)
Table 33. Global Influenza NA Inhibitor Revenue Share by Type (2023-2028)
Table 34. Influenza NA Inhibitor Price by Type (2017-2022) & (US$/Kg)
Table 35. Global Influenza NA Inhibitor Price Forecast by Type (2023-2028) & (US$/Kg)
Table 36. Global Influenza NA Inhibitor Sales by Application (2017-2022) & (Kilotons)
Table 37. Global Influenza NA Inhibitor Sales by Application (2023-2028) & (Kilotons)
Table 38. Global Influenza NA Inhibitor Sales Share by Application (2017-2022)
Table 39. Global Influenza NA Inhibitor Sales Share by Application (2023-2028)
Table 40. Global Influenza NA Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Influenza NA Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Influenza NA Inhibitor Revenue Share by Application (2017-2022)
Table 43. Global Influenza NA Inhibitor Revenue Share by Application (2023-2028)
Table 44. Influenza NA Inhibitor Price by Application (2017-2022) & (US$/Kg)
Table 45. Global Influenza NA Inhibitor Price Forecast by Application (2023-2028) & (US$/Kg)
Table 46. North America Influenza NA Inhibitor Sales by Type (2017-2022) & (Kilotons)
Table 47. North America Influenza NA Inhibitor Sales by Type (2023-2028) & (Kilotons)
Table 48. North America Influenza NA Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Influenza NA Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Influenza NA Inhibitor Sales by Application (2017-2022) & (Kilotons)
Table 51. North America Influenza NA Inhibitor Sales by Application (2023-2028) & (Kilotons)
Table 52. North America Influenza NA Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Influenza NA Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Influenza NA Inhibitor Sales by Country (2017-2022) & (Kilotons)
Table 55. North America Influenza NA Inhibitor Sales by Country (2023-2028) & (Kilotons)
Table 56. North America Influenza NA Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Influenza NA Inhibitor Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Influenza NA Inhibitor Sales by Type (2017-2022) & (Kilotons)
Table 59. Europe Influenza NA Inhibitor Sales by Type (2023-2028) & (Kilotons)
Table 60. Europe Influenza NA Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Influenza NA Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Influenza NA Inhibitor Sales by Application (2017-2022) & (Kilotons)
Table 63. Europe Influenza NA Inhibitor Sales by Application (2023-2028) & (Kilotons)
Table 64. Europe Influenza NA Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Influenza NA Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Influenza NA Inhibitor Sales by Country (2017-2022) & (Kilotons)
Table 67. Europe Influenza NA Inhibitor Sales by Country (2023-2028) & (Kilotons)
Table 68. Europe Influenza NA Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Influenza NA Inhibitor Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Influenza NA Inhibitor Sales by Type (2017-2022) & (Kilotons)
Table 71. Asia Pacific Influenza NA Inhibitor Sales by Type (2023-2028) & (Kilotons)
Table 72. Asia Pacific Influenza NA Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Influenza NA Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Influenza NA Inhibitor Sales by Application (2017-2022) & (Kilotons)
Table 75. Asia Pacific Influenza NA Inhibitor Sales by Application (2023-2028) & (Kilotons)
Table 76. Asia Pacific Influenza NA Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Influenza NA Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Influenza NA Inhibitor Sales by Region (2017-2022) & (Kilotons)
Table 79. Asia Pacific Influenza NA Inhibitor Sales by Region (2023-2028) & (Kilotons)
Table 80. Asia Pacific Influenza NA Inhibitor Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Influenza NA Inhibitor Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Influenza NA Inhibitor Sales by Type (2017-2022) & (Kilotons)
Table 83. Latin America Influenza NA Inhibitor Sales by Type (2023-2028) & (Kilotons)
Table 84. Latin America Influenza NA Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Influenza NA Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Influenza NA Inhibitor Sales by Application (2017-2022) & (Kilotons)
Table 87. Latin America Influenza NA Inhibitor Sales by Application (2023-2028) & (Kilotons)
Table 88. Latin America Influenza NA Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Influenza NA Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Influenza NA Inhibitor Sales by Country (2017-2022) & (Kilotons)
Table 91. Latin America Influenza NA Inhibitor Sales by Country (2023-2028) & (Kilotons)
Table 92. Latin America Influenza NA Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Influenza NA Inhibitor Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Influenza NA Inhibitor Sales by Type (2017-2022) & (Kilotons)
Table 95. Middle East and Africa Influenza NA Inhibitor Sales by Type (2023-2028) & (Kilotons)
Table 96. Middle East and Africa Influenza NA Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Influenza NA Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Influenza NA Inhibitor Sales by Application (2017-2022) & (Kilotons)
Table 99. Middle East and Africa Influenza NA Inhibitor Sales by Application (2023-2028) & (Kilotons)
Table 100. Middle East and Africa Influenza NA Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Influenza NA Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Influenza NA Inhibitor Sales by Country (2017-2022) & (Kilotons)
Table 103. Middle East and Africa Influenza NA Inhibitor Sales by Country (2023-2028) & (Kilotons)
Table 104. Middle East and Africa Influenza NA Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Influenza NA Inhibitor Revenue by Country (2023-2028) & (US$ Million)
Table 106. Green Cross Corporation Information
Table 107. Green Cross Description and Major Businesses
Table 108. Green Cross Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 109. Green Cross Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Green Cross Recent Developments
Table 111. Roche Corporation Information
Table 112. Roche Description and Major Businesses
Table 113. Roche Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 114. Roche Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Roche Recent Developments
Table 116. GlaxoSmithKline Corporation Information
Table 117. GlaxoSmithKline Description and Major Businesses
Table 118. GlaxoSmithKline Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 119. GlaxoSmithKline Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. GlaxoSmithKline Recent Developments
Table 121. Henan DaKen Chemical Corporation Information
Table 122. Henan DaKen Chemical Description and Major Businesses
Table 123. Henan DaKen Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 124. Henan DaKen Chemical Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Henan DaKen Chemical Recent Developments
Table 126. ATK Chemical Corporation Information
Table 127. ATK Chemical Description and Major Businesses
Table 128. ATK Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 129. ATK Chemical Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. ATK Chemical Recent Developments
Table 131. Chemwill Asia Co.,Ltd. Corporation Information
Table 132. Chemwill Asia Co.,Ltd. Description and Major Businesses
Table 133. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 134. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Chemwill Asia Co.,Ltd. Recent Developments
Table 136. Shionogi Co. Corporation Information
Table 137. Shionogi Co. Description and Major Businesses
Table 138. Shionogi Co. Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 139. Shionogi Co. Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Shionogi Co. Recent Developments
Table 141. NeoPharm Corporation Information
Table 142. NeoPharm Description and Major Businesses
Table 143. NeoPharm Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 144. NeoPharm Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. NeoPharm Recent Developments
Table 146. Moksha8 Pharma Corporation Information
Table 147. Moksha8 Pharma Description and Major Businesses
Table 148. Moksha8 Pharma Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 149. Moksha8 Pharma Influenza NA Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Moksha8 Pharma Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Influenza NA Inhibitor Distributors List
Table 154. Influenza NA Inhibitor Customers List
Table 155. Influenza NA Inhibitor Market Trends
Table 156. Influenza NA Inhibitor Market Drivers
Table 157. Influenza NA Inhibitor Market Challenges
Table 158. Influenza NA Inhibitor Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza NA Inhibitor Product Picture
Figure 3. Global Influenza NA Inhibitor Market Share by Type in 2021 & 2028
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Global Influenza NA Inhibitor Market Share by Application in 2021 & 2028
Figure 7. Influenza A Treatment
Figure 8. Influenza B Treatment
Figure 9. Influenza NA Inhibitor Report Years Considered
Figure 10. Global Influenza NA Inhibitor Sales 2017-2028 (Kilotons)
Figure 11. Global Influenza NA Inhibitor Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Influenza NA Inhibitor Revenue 2017-2028 (US$ Million)
Figure 13. Global Influenza NA Inhibitor Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Influenza NA Inhibitor Sales Market Share by Region (2017-2022)
Figure 15. Global Influenza NA Inhibitor Sales Market Share by Region (2023-2028)
Figure 16. North America Influenza NA Inhibitor Sales YoY (2017-2028) & (Kilotons)
Figure 17. North America Influenza NA Inhibitor Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Influenza NA Inhibitor Sales YoY (2017-2028) & (Kilotons)
Figure 19. Europe Influenza NA Inhibitor Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Influenza NA Inhibitor Sales YoY (2017-2028) & (Kilotons)
Figure 21. Asia-Pacific Influenza NA Inhibitor Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Influenza NA Inhibitor Sales YoY (2017-2028) & (Kilotons)
Figure 23. Latin America Influenza NA Inhibitor Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Influenza NA Inhibitor Sales YoY (2017-2028) & (Kilotons)
Figure 25. Middle East & Africa Influenza NA Inhibitor Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Influenza NA Inhibitor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Influenza NA Inhibitor in the World: Market Share by Influenza NA Inhibitor Revenue in 2021
Figure 28. Global Influenza NA Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Influenza NA Inhibitor Sales Market Share by Type (2017-2028)
Figure 30. Global Influenza NA Inhibitor Revenue Market Share by Type (2017-2028)
Figure 31. Global Influenza NA Inhibitor Sales Market Share by Application (2017-2028)
Figure 32. Global Influenza NA Inhibitor Revenue Market Share by Application (2017-2028)
Figure 33. North America Influenza NA Inhibitor Sales Market Share by Type (2017-2028)
Figure 34. North America Influenza NA Inhibitor Revenue Market Share by Type (2017-2028)
Figure 35. North America Influenza NA Inhibitor Sales Market Share by Application (2017-2028)
Figure 36. North America Influenza NA Inhibitor Revenue Market Share by Application (2017-2028)
Figure 37. North America Influenza NA Inhibitor Sales Share by Country (2017-2028)
Figure 38. North America Influenza NA Inhibitor Revenue Share by Country (2017-2028)
Figure 39. U.S. Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Influenza NA Inhibitor Sales Market Share by Type (2017-2028)
Figure 42. Europe Influenza NA Inhibitor Revenue Market Share by Type (2017-2028)
Figure 43. Europe Influenza NA Inhibitor Sales Market Share by Application (2017-2028)
Figure 44. Europe Influenza NA Inhibitor Revenue Market Share by Application (2017-2028)
Figure 45. Europe Influenza NA Inhibitor Sales Share by Country (2017-2028)
Figure 46. Europe Influenza NA Inhibitor Revenue Share by Country (2017-2028)
Figure 47. Germany Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 48. France Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Influenza NA Inhibitor Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Influenza NA Inhibitor Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Influenza NA Inhibitor Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Influenza NA Inhibitor Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Influenza NA Inhibitor Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Influenza NA Inhibitor Revenue Share by Region (2017-2028)
Figure 58. China Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 61. India Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Influenza NA Inhibitor Sales Market Share by Type (2017-2028)
Figure 69. Latin America Influenza NA Inhibitor Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Influenza NA Inhibitor Sales Market Share by Application (2017-2028)
Figure 71. Latin America Influenza NA Inhibitor Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Influenza NA Inhibitor Sales Share by Country (2017-2028)
Figure 73. Latin America Influenza NA Inhibitor Revenue Share by Country (2017-2028)
Figure 74. Mexico Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Influenza NA Inhibitor Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Influenza NA Inhibitor Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Influenza NA Inhibitor Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Influenza NA Inhibitor Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Influenza NA Inhibitor Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Influenza NA Inhibitor Revenue Share by Country (2017-2028)
Figure 83. Turkey Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Influenza NA Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 86. Influenza NA Inhibitor Value Chain
Figure 87. Influenza NA Inhibitor Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
